-
International Journal of Nanomedicine
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Nanomedicine for the reduction of the thrombogenicity of stent coatings
Original Research
(2548) Views (771) Full article downloads
Authors: Varvara C Karagkiozaki, Stergios D Logothetidis, Spyridon N Kassavetis, et al
Published Date March 2010
Volume 2010:5 Pages 239 - 248
DOI: http://dx.doi.org/10.2147/IJN.S7596
Varvara C Karagkiozaki1,2, Stergios D Logothetidis2, Spyridon N Kassavetis2, George D Giannoglou1
1Aristotle University of Thessaloniki, Medical School, AHE PA University General Hospital, 1st Cardiology Department, Cardiovascular Engineering and Atherosclerosis Laboratory, Greece; 2Aristotle University of Thessaloniki, Physics Department, Laboratory for Thin Films – Nanosystems and Nanometrology (LTFN), Greece
Abstract: The treatment of patients with drug-eluting stents (DES) continues to evolve with the current emergence of DES technology that offers a combination of pharmacological and mechanical approaches to prevent arterial restenosis. However, despite the promising short-term and mid-term outcomes of DES, there are valid concerns about adverse clinical effects of late stent thrombosis. In this study, we present an example of how nanomedicine can offer solutions for improving stent coating manufacturing, by producing nanomaterials with tailored and controllable properties. The study is based on the exploitation of human platelets response towards carbon-based nanocoatings via atomic force microscope (AFM). AFM can facilitate the comprehensive analysis of platelets behavior onto stent nanocoatings and enable the study of thrombogenicity. Platelet-rich plasma from healthy donors was used for the real-time study of biointerfacial interactions. The carbon nanomaterials were developed by rf magnetron sputtering technique under controllable deposition conditions to provide favorable surface nanotopography. It was shown that by altering the surface topography of nanocoatings, the activation of platelets can be affected, while the carbon nanocoatings having higher surface roughness were found to be less thrombogenic in terms of platelets adhesion. This is an actual solution for improving the stent coating fabrication.
Keywords: stents nanomedicine, carbon coating, atomic force microscopy platelets nanotechnology
Other articles by Professor Stergios Logothetidis
Readers of this article also read:
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
The pathophysiology of bronchiectasis
Atomic force microscopy probing in the measurement of cell mechanics
Decreased lung carcinoma cell density on select polymer nanometer surface features for lung replacement therapies
Cell engineering: nanometric grafting of poly-N-isopropylacrylamide onto polystyrene film by different doses of gamma radiation
Types of neural guides and using nanotechnology for peripheral nerve reconstruction
Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines
Anticancer efficacy of perillyl alcohol-bearing PLGA microparticles
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Interested in being a peer-reviewer?
Click here to register.
- Display new articles on your site
Use our widget to show articles on your own site
- Applications of gold nanoparticles in cancer nanotechnology
- Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer
- Gold nanoparticles: From nanomedicine to nanosensing
- Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases




